Prof. Paul Dendale ,
Impact of Cardiac Rehabilitation on Mortality and Cardiovascular Events After Percutaneous Coronary Intervention in the Community Kashish Goel, MBBS; Ryan J. Lennon, MS; R. Thomas Tilbury, MD; Ray W. Squires, PhD; Randal J. Thomas, MD, MS Circulation. 2011;123:2344-2352 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention Cardiac rehabilitation G. N. Levine, et al. Circulation 2011, 124:2574-2609
This large US study by Goel et al. confirms the effects of CR on all-cause mortality. This result was present in elective or urgent procedures, in both sexes, and all age groups. The absence of an effect on infarction and revascularisation might seem strange (even though a composite of death, revascularisation and infarction was also reduced by CR). The difference in follow-up might be one possible explanation (in CR patients recurrent ischemia will more easily be detected and treated by revascularisation), the other is a possible shift from fatal to non-fatal events due to physical training. This important study underlines the importance of referral of patients after PCI to cardiac rehabilitation: regular exercise and good food might be a powerful way to prevent ischemic events from killing your patient. The indication for referral of patients after revascularization was already mentioned in the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) "Guidelines on myocardial revascularization". But now, for the first time, Cardiac rehabilitation is a level of evidence I A indication after revascularisation, according to the new US guidelines on PCI: “Medically supervised exercise programs (cardiac rehabilitation) should be recommended to patients after PCI, particularly for patients at moderate to high risk for whom supervised exercise training is warranted: level of evidence I A”. This guideline is “based on multiple randomised trials or meta-analyses”. So, let’s have those patients in CR!
Our mission: To reduce the burden of cardiovascular disease
© 2017 European Society of Cardiology. All rights reserved